Exhibit 4.14

 SCHEDULE OF DOCUMENTS SIMILAR TO EXHIBIT 4.13 THAT HAVE BEEN OMITTED FROM THIS
  ANNUAL REPORT ON FORM 10-K (WITH AN EXPLANATION OF MATERIAL DETAILS IN WHICH
                SUCH OMITTED DOCUMENTS DIFFER FROM EXHIBIT 4.13).

     On  October  26,  2007,  Cavit  Sciences,  Inc.  issued a series of Class H
warrants to purchase  Cavit common  stock to four of its  original  investors in
consideration for said four investors forever waiving their anti-dilution rights
with respect to future  issuances of Cavit  common  stock.  Cavit has elected to
omit from its exhibits to this Annual  Report  actual copies of some of warrants
due to the voluminous and redundant nature of such additional warrants.

     While the majority of the  language,  terms and  conditions  of the various
warrants are identical,  the warrants differ in four areas:  (i) name of warrant
holders;  (ii) number of shares of common stock covered by the  warrants;  (iii)
exercise price of the warrants and (iv) term of the warrants.

The following  table explains the  differences in the omitted  warrants from the
warrant attached to this Annual Report as Exhibit 4.13:

                              Number of
Name of Holder              Shares Covered     Exercise Price       Term
- --------------              --------------     --------------       ----

Raymond Bazley                 100,000             $ .55        Sixty months
Cortland Fund, LLC             100,000             $ .55
Margaret Smyth                 100,000             $ .55        Sixty months
Robert Hennen                   13,334             $ .55        Sixty months